与帕金森病相关的认知障碍的分子机制:中风的前景
Sanju Gupta1, Juhee Khan1, Surajit Ghosh1
1Department of Bioscience & Bioengineering, Indian Institute of Technology Jodhpur (IIT-Jodhpur), Rajasthan 342037, India.
Life sciences
|December 21, 2023
概括
帕金森病 (PD) 和中风具有共同的分子联系,特别是在引起认知衰退和记忆丧失方面. 本综述探讨了这两种神经疾病的这些联系和潜在的药物点.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,其特点是运动和非运动症状.
- 流行病学研究将PD与死亡率的增加和中风发病率的显著关联,包括脑梗塞和出血.
- 脑卒中和PD都与认知障碍 (如痴呆症) 独立相关,但潜在的分子机制仍然不清楚.
研究的目的:
- 审查中风和帕金森病之间的关系.
- 在这两种情况中强调了潜在的认知缺陷和记忆丧失的分子机制.
- 突出潜在的治疗药物分子,针对PD和中风.
主要方法:
- 文献综述侧重于PD和中风的交叉点.
- 对导致PD和中风认知障碍的分子机制的分析.
- 识别和讨论潜在的候选药物.
主要成果:
- 脑卒中发生率,包括心脏病发作和出血,与PD发展有很大关系.
- 认知障碍,主要是痴呆症,与中风和PD有关.
- 驱动这些共享认知缺陷的分子机制目前尚不清楚.
结论:
- 了解中风和PD之间的分子联系对于解决共同的认知症状至关重要.
- 对这些分子通路的进一步研究可能会揭示新的治疗点.
- 针对共同途径的潜在药物分子可以为PD和中风患者提供联合治疗益处.
相关概念视频
Parkinson's Disease: Overview
554
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
554
Parkinson's Disease: Treatment
274
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
274
Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492


